OPIANT PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Operating Activities in USD from 2011 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Opiant Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2011 to 2021.
  • Opiant Pharmaceuticals, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2022 was -$2.1M, a 223% decline year-over-year.
  • Opiant Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was $1.93M.
  • Opiant Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$2.03M, a 150% decline from 2019.
  • Opiant Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2019 was $4.06M.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $1.93M +$3.96M Jan 1, 2021 Dec 31, 2021 10-K 2022-03-15
2020 -$2.03M -$6.09M -150% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $4.06M +$4.59M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 -$523K -$6.08M -109% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-04
2017 $5.56M +$6.47M Aug 1, 2016 Jul 31, 2017 10-K 2019-03-21
2016 -$915K Aug 1, 2015 Jul 31, 2016 10-K 2017-10-13
2013 -$747K +$349K +31.9% Aug 1, 2012 Jul 31, 2013 10-K 2013-10-29
2012 -$1.1M +$1.86M +62.9% Aug 1, 2011 Jul 31, 2012 10-K 2013-10-29
2011 -$2.96M Aug 1, 2010 Jul 31, 2011 10-K/A 2012-11-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.